Associated Papers
Prognostic and functional role of PPAR-alpha and SNP receptor (Leu162Val) in acute coronary syndrome: a potential novel target.
Raeef AA et al.
Journal, Genetic Engineering & Biotechnology, 2025
Polymorphic Variants of Selected Genes Regulating Bile Acid Homeostasis in Women with Intrahepatic Cholestasis of Pregnancy.
Piątek K et al.
International Journal of Molecular Sciences, 2025
Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver disease.
Wang JJ et al.
Frontiers in Physiology, 2025
Target gene variations of PPAR isoforms may contribute to MODY heterogeneity: A preliminary comparative study with type 2 diabetes.
Yilmaz-Aydogan H et al.
Diabetes Research and Clinical Practice, 2024
Genetic Variants of Obesity in Malaysia: A Scoping Review.
Hamzah SS et al.
Genes, 2024
APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial.
Sun G et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids, 2024
An association between PPARα-L162V polymorphism and increased plasma LDL cholesterol levels after risperidone treatment.
Nadalin S et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids, 2024
C Allele of the PPARδ+294T>C Polymorphism Confers a Higher Risk of Hypercholesterolemia, but not Obesity and Insulin Resistance: A Systematic Review and Meta-Analysis.
Li S et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, 2023
Association between Genotype and the Glycemic Response to an Oral Glucose Tolerance Test: A Systematic Review.
Bayer S et al.
Nutrients, 2023
Frequencies of variants in genes associated with dyslipidemias identified in Costa Rican genomes.
Valverde-Hernández JC et al.
Frontiers in Genetics, 2023
Decoding the genetic relationship between Alzheimer's disease and type 2 diabetes: potential risk variants and future direction for North Africa.
Boukhalfa W et al.
Frontiers in Aging Neuroscience, 2023
Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
Handelman SK et al.
Hepatology Communications, 2022
Metabolic syndrome and underlying genetic determinants-A systematic review.
Rana S et al.
Journal of Diabetes and Metabolic Disorders, 2022
The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome.
Kemanci A et al.
Cureus, 2022
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts.
Dagli-Hernandez C et al.
Pharmacological Reports : Pr, 2022
Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.
Ricciardello A et al.
American Journal of Medical Genetics. Part A, 2021
Does polymorphisms in PPAR and APOE genes modify associations between fatty acid desaturase (FADS), n-3 long-chain PUFA and cardiometabolic markers in 8-11-year-old Danish children?
Damsgaard CT et al.
The British Journal of Nutrition, 2021
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
Exome-Wide Search for Genes Associated With Central Nervous System Inflammatory Demyelinating Diseases Following CHIKV Infection: The Tip of the Iceberg.
Alves-Leon SV et al.
Frontiers in Genetics, 2021
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.
Wada Y et al.
Ebiomedicine, 2020
Variants and expression changes in PPAR-encoding genes display no significant association with schizophrenia.
Li X et al.
Bioscience Reports, 2020
Pro12Ala PPAR-γ2 and +294T/C PPAR-δ Polymorphisms and Association with Metabolic Traits in Teenagers from Northern Mexico.
Carrillo-Venzor MA et al.
Genes, 2020
Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
Sprissler R et al.
Cancers, 2020
Association of common gene-smoking interactions with elevated plasma apolipoprotein B concentration.
Roy N et al.
Lipids in Health and Disease, 2020
Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α.
Sáez-Orellana F et al.
Cells, 2020
Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events.
Saki S et al.
Middle East Journal of Digestive Diseases, 2020
Genetic variants associated with exercise performance in both moderately trained and highly trained individuals.
Harvey NR et al.
Molecular Genetics and Genomics : Mgg, 2020
Heritability and Genetics of Type 2 Diabetes Mellitus in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Asamoah EA et al.
Journal of Diabetes Research, 2020
Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and Atherosclerosis.
Ruscica M et al.
International Journal of Molecular Sciences, 2019
The Polymorphisms of the Peroxisome-Proliferator Activated Receptors' Alfa Gene Modify the Aerobic Training Induced Changes of Cholesterol and Glucose.
Maciejewska-Skrendo A et al.
Journal of Clinical Medicine, 2019
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
Association between PPARs Gene Functional Polymorphisms and Ischemic Stroke in Chinese Uyghur Population.
Tong Y et al.
The Journal of Nutrition, Health & Aging, 2019
Genetic polymorphisms of PPAR genes and human cancers: evidence for gene-environment interactions.
Dhaini HR et al.
Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 2019
The Association of Polymorphisms in Circadian Clock and Lipid Metabolism Genes With 2nd Trimester Lipid Levels and Preterm Birth.
Kovac U et al.
Frontiers in Genetics, 2019
Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease.
Miyaaki H et al.
Clinical Journal of Gastroenterology, 2017
Genetic Obesity Risk and Attenuation Effect of Physical Fitness in Mexican-Mestizo Population: a Case-Control Study.
Costa-Urrutia P et al.
Annals of Human Genetics, 2017
The insertion/deletion polymorphism in the angiotensin-converting enzyme gene and nicotine dependence in schizophrenia patients.
Nadalin S et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2017
Genetic variation in the 3'-untranslated region of PAK1 influences schizophrenia susceptibility.
Jiang J et al.
Experimental and Therapeutic Medicine, 2017
An association between the PPARα-L162V polymorphism and nicotine dependency among patients with schizophrenia.
Nadalin S et al.
Comprehensive Psychiatry, 2016
The association of peroxisome proliferator-activated receptor α with diabetic retinopathy, and additional gene-obesity interaction in Chinese type 2 diabetes mellitus patients.
Qi S et al.
Obesity Research & Clinical Practice, 2016
Interaction Between Peroxisome Proliferator Activated Receptor δ and Epithelial Membrane Protein 2 Polymorphisms Influences HDL-C Levels in the Chinese Population.
Ke T et al.
Annals of Human Genetics, 2016
Genetics of nonalcoholic fatty liver disease.
Dongiovanni P et al.
Metabolism: Clinical and Experimental, 2016
Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y et al.
Medicine, 2016
Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.
Yang Y et al.
Endocrine Reviews, 2016
Functional Genetic Variants of PPARx03B3; and PPARα Encoding Peroxisome Proliferator-Activated Receptors and Susceptibility to Ischemic Stroke in Chinese Han Population.
Tong Y et al.
Cerebrovascular Diseases (basel, Switzerland), 2016
Screening of Peroxisome Proliferator-Activated Receptors (PPARs) α, γ and α Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population.
Chia PP et al.
Ethnicity & Disease, 2015
Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study.
Ling Q et al.
Medicine, 2015